What Is The Current and Historic Market Size Analysis Of The Recombinant Proteins Market?
The recombinant proteins market has seen considerable growth due to a variety of factors.
• In recent years, there has been significant growth in the market size of recombinant proteins. It is projected to expand from $2.31 billion in 2024 to $2.57 billion in 2025, with a compound annual growth rate (CAGR) of 11.3%. The surge experienced in the historical period can be linked to factors such as a rising demand for biopharmaceuticals, an increase in chronic diseases, an expanding aging population, government initiatives and funding, as well as growth in its applications in research and diagnostics.
What Are The Predictions for The Recombinant Proteins Market Size Evolve over the Forecast Period?
The Recombinant Proteins market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of recombinant proteins is predicted to undergo swift expansion in the coming years, reaching a valuation of $4.3 billion in 2029 with a compounded annual growth rate (CAGR) of 13.7%.
This accelerated growth through the forecast period can be linked to the heightened utilization of personalized medicine, the rapid development of the biotechnology industry, global initiatives to combat rare diseases, progress in protein manipulation methods, growing markets, and unexplored opportunities. The forecast period will likely see the expanded use of personalized medicine, significant growth in the biotechnology industry, increased demand for therapeutic proteins, the rise of new therapeutic targets, and a world-wide emphasis on vaccine creation.
Which Drivers Are Accelerating Growth In The Recombinant Proteins Market?
Emphasizing a patient's unique genetic composition and needs, the escalating interest in personalized medicine is predicted to spur the upward trajectory of the recombinant protein market. Personalized medicine embodies a healthcare strategy customized to an individual's genetics, traits, and requirements which aims to enhance healthcare results by delivering more effective and personalized treatments. The surge in personalized medicine is a result of major improvements in genomic technologies and data analysis which allows for patient-specific treatments based on their unique genetic structures. Recombinant proteins further this cause by facilitating individually tailored therapies that target a person's distinctive genetic and molecular makeup, ultimately leading to more effective treatments and lowered side effect risks. In 2024, the Personalized Medicine Coalition, an American non-profit group, reported an increase in FDA-approved personalized treatments for patients suffering from uncommon diseases: 16 new treatments in 2023, compared to only six in 2022. Consequently, the rapidly expanding focus on personalized medicine is fueling the upward momentum of the recombinant protein market.
What Are The Core Segments Of The Global Recombinant Proteins Market?
The recombinant proteins market covered in this report is segmented –
1) By Product: Antibodies, Cytokines, Immune Checkpoint Protein, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Application: Drug And Discovery Development, Therapeutics, Research, Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies
2) By Cytokines: Interleukins, Interferons, Tumor Necrosis Factors (TNFs)
3) By Immune Checkpoint Proteins: PD-1 Or PD-L1 Inhibitors, CTLA-4 Inhibitors
4) By Virus Antigens: Viral Capsid Proteins, Envelope Proteins
5) By Enzymes: Restriction Enzymes, Polymerases, Ligases
6) By Recombinant Regulatory Proteins: Transcription Factors, Receptors, Hormones
7) By Hormones: Insulin, Growth Hormones
8) By Other Products: Fusion Proteins, Peptide Therapeutics
Pre-Book The Recombinant Proteins Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Recombinant Proteins Market Size?
Product creativity is becoming an influential trend in the recombinant protein market. Major firms in this sector are emphasizing the creation of original products to solidify their market standing. For instance, ProteoGenix, a biochemistry firm based in France, introduced the XtenCHO Transient CHO Expression System in March 2022, intended to enhance biologics' development. This novel system provides a multitude of benefits, such as yields that are ten times higher, improved plasmid stability, and user-friendly protocols that require fewer hands-on time. The XtenCHO system is constructed to be a swift, budget-friendly answer, perfect for bioanalytical applications and drug development process.
Who Are the Key Players In The Recombinant Proteins Market?
Major companies operating in the recombinant proteins market include:
• Abcam plc
• Abnova Corporation
• Bio-Rad Laboratoroies Inc.
• Merck Co. & KGaA
• R&D Systems Inc.
• Proteintech Group Inc.
• RayBiotech Life Inc.
• GenScript Biotech Corporation
• Elpiscience Biopharmaceuticals Co. Ltd.
• Elevian Inc.
• Gigagen Inc.
• Janssen- Cilag Pvt. Ltd.
• Sino Biological Inc.
• OriGene Technologies Inc.
• Feldan Therapeutics Inc.
• Randox Laboratories Ltd.
• Bio-Techne Corporation
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Crown Bioscience Inc.
• Airway Therapeutics Inc.
• Amgen Inc.
• Aviva Systems Biology Corp.
• Eli Lilly and Company
What Are The Regional Insights Into The Recombinant Proteins Market?
North America was the largest region in the recombinant protein market in 2024. The regions covered in the recombinant proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
